Hip replacement recovery goes digital: app-based rehab tested against standard care

NCT ID NCT06780319

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study compares a home-based digital rehabilitation program (using a mobile app and remote physiotherapist guidance) to standard in-person physical therapy after total hip replacement. The goal is to see if the digital approach can improve mobility and patient-reported outcomes just as well, while overcoming barriers like travel and scheduling. Sixty adults who have had a hip replacement will be followed for six months, with their mobility measured using the Timed Up and Go test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tele-rehabilitation (mobile app with remote physiotherapist monitoring)
What this could lead to
If effective, tele-rehabilitation could offer a convenient, accessible alternative to in-person physical therapy after hip replacement, potentially improving recovery for many patients.
What could go wrong
This is a small, early-stage trial (60 participants) comparing tele-rehab to no formal therapy, so results may not apply broadly. The digital approach may not suit all patients, and technical issues could affect outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIP ARTHROPLASTY, TOTAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinique du Sport

    RECRUITING

    Mérignac, 33700, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.